ticlopidine has been researched along with Nephritis in 4 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Nephritis: Inflammation of any part of the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the antiplatelet agents, ticlopidine and dipyridamole, on nephrotoxic serum nephritis (NTN) was evaluated in rats." | 7.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Sasayama, S, 1987) |
| "The effect of the antiplatelet agents, ticlopidine and dipyridamole, on nephrotoxic serum nephritis (NTN) was evaluated in rats." | 3.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Sasayama, S, 1987) |
| "Here we found that renal ischemia reperfusion injury in mice leads to increased platelet activation in immediate proximity of necrotic cell casts." | 1.46 | Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. ( Dessing, MC; Emal, D; Florquin, S; Jansen, MP; Roelofs, JJ; Teske, GJ, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jansen, MP | 1 |
| Emal, D | 1 |
| Teske, GJ | 1 |
| Dessing, MC | 1 |
| Florquin, S | 1 |
| Roelofs, JJ | 1 |
| Madanick, RD | 1 |
| Ogawa, S | 1 |
| Naruse, T | 1 |
| Izumino, K | 1 |
| Iida, H | 1 |
| Asaka, M | 1 |
| Sasayama, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Institute of Emergency and Critical Care Medicine , School of Yang-Ming University[NCT01588886] | 9,000 participants (Actual) | Observational | 2012-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ticlopidine and Nephritis
| Article | Year |
|---|---|
Proton pump inhibitor side effects and drug interactions: much ado about nothing?
Topics: Anemia, Iron-Deficiency; Anti-Ulcer Agents; Clopidogrel; Drug Interactions; Fractures, Spontaneous; | 2011 |
3 other studies available for ticlopidine and Nephritis
| Article | Year |
|---|---|
Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps.
Topics: Animals; Blood Platelets; Cell Line; Clopidogrel; Disease Models, Animal; DNA; Epithelial Cells; Ext | 2017 |
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
Topics: Animals; Anticoagulants; Aspirin; Batroxobin; Blood Platelets; Dipyridamole; Glomerulonephritis; Imm | 1982 |
Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats.
Topics: Animals; Dipyridamole; Immune Complex Diseases; Nephritis; Platelet Aggregation; Proteinuria; Rats; | 1987 |